Business

Nanox Announces Fourth Quarter of 2025 Financial Results and Provides Business Updates

Advanced commercialization in the US, signing multiple new customer and distribution agreements for Nanox.ARC and accelerated activities around Nanox.AI Management to host conference call and webcast Monday, April 20, 2026 at 8:30 AM ET Appointed new CFO effective August 1, 2026 PETAH TIKVA, Israel, April 20, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced results for the fourth quarter ended

articleNano-x Imaging LtdApril 20, 202637/company/nano-x-imaging-ltd/news/nanox-announces-fourth-quarter-of-2025-financial-results-and-provides-business-updates
Nanox Announces Fourth Quarter of 2025 Financial Results and Provides Business Updates

About this update from Nano-x Imaging Ltd

[{"type":"image","alt":"Nano-X Imaging Ltd","displaySize":"","headline":null,"caption":"Nano-X Imaging Ltd","className":"","disableSlideshowImg":false,"size":{"original":{"width":250,"height":64,"url":"https://media.zenfs.com/en/globenewswire.com/bb68e1b6e7ee0b6ba64825d135e6c05a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/KOXI3J_9rZ8jvU5PCp.DvQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEwOA--/https://media.zenfs.com/en/globenewswire.com/bb68e1b6e7ee0b6ba64825d135e6c05a","width":250,"height":64}},"lazy":false},{"type":"text","content":"Advanced commercialization in the US, signing multiple new customer and distribution agreements for Nanox.ARC and accelerated activities around Nanox.AI","length":152,"tagName":"p"},{"type":"text","content":"Management to host conference call and webcast Monday, April 20, 2026 at 8:30 AM ET","length":83,"tagName":"p"},{"type":"text","content":"Appointed new CFO effective August 1, 2026","length":42,"tagName":"p"},{"type":"text","content":"PETAH TIKVA, Israel, April 20, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced results for the fourth quarter ended December 31, 2025, and provided a business update.","length":271,"tagName":"p"},{"type":"text","content":"Recent Highlights:","length":18,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Generated $3.7 million in revenue in the fourth quarter of 2025, compared to $3.0 million in the fourth quarter of 2024.","length":120,"tagName":"p"}]},{"val":[{"type":"text","content":"Completed the acquisition of 100% of the stock of Vaso Healthcare IT Corp. (now Nanox Health IT Inc., “Nanox Health IT”), a provider of healthcare information technologies solutions, for cash and future operational based earnouts.","length":230,"tagName":"p"}]},{"val":[{"type":"text","content":"Entered into a distribution agreement with Howard Technology Solutions (“Howard”), a division of Howard Industries to deploy 300 Nanox.ARC systems across the U.S. over three years.","length":180,"tagName":"p"}]},{"val":[{"type":"text","content":"Initiated a restructuring of semiconductor manufacturing operations at Nanox’ South Korean facility to reduce operating expenses and enhance manufacturing efficiencies, while also taking steps to secure the Company’s supply chain.","length":230,"tag...

More updates from Nano-x Imaging Ltd

the Companythe Companymanufacturing operationsChief Financial OfficerChief Financial OfficerNanox Health IT Inc.Company